Browse Articles
Discover research articles across all indexed journals
Large Exchange Bias Effect in Geometrically Frustrated Spin Glass Through High‐Density Coherent Chemical Interfaces
ABSTRACT The pursuit of next‐generation spintronic devices has focused heavily on compensated ferrimagnets and non‐collinear antiferromagnets, thanks to their significant exchange bias (EB) effects and minimal stray fields. However, spin glass (SG) systems are reemerging as compelling candidates despite their historically weak EB responses and poorly understood pinning mechanisms. Herein, we report the discovery of a geometrically frustrated SG intermetal material (Mn 32 Co 5 In 15 ) exhibiting large EB effects (∼0.3 T), achieved by engineering high‐density coherent interfaces. Specifically, this material features a 3D interlaced structure consisting of frustrated antiferromagnetic (f‐AFM) Mn‐rich clusters and ferromagnetic‐like (FML) In‐dominant clusters, consistent with topological spin glass states. Using field‐dependent neutron scattering combined with theoretical calculations, we established the first experimental evidence that the large EB arises from the local pinning of FML states within frozen, coherent f‐AFM matrices. This pinning breaks the ergodicity inherent to typical SG systems, while spin polarization of FML clusters creates an energetically favorable anisotropic channel in response to external fields. These findings offer new possibilities for leveraging frustrated spin glasses as pivotal functional materials in spintronic devices.
The prognostic significance of MYBL1 and MYBL2 genes in low-grade glioma.
73 Background: Low-grade gliomas (LGG) demonstrate heterogeneous clinical behavior despite shared histologic classification. Identifying transcriptional regulators associated with tumor aggressiveness may improve prognostic stratification. MYBL1 and MYBL2 are cell cycle–associated transcription factors implicated in oncogenesis, but their prognostic significance in LGG remains unclear. Methods: RNA sequencing and clinical data from 516 patients in the TCGA-LGG cohort were analyzed. MYBL1 and MYBL2 expression (log2[TPM+1]) were compared across astrocytoma (n=98), oligoastrocytoma (n=76), oligodendroglioma (n=116), and normal brain tissue (n=207). Overall survival (OS) was assessed using Kaplan Meier analysis and multivariate cox proportional hazards models adjusted for histology, grade, age at diagnosis, and IDH status. Gene set enrichment analysis (GSEA) was performed using Reactome, KEGG, MSigDB Hallmark, and GO databases. R v4.3.3 was used for all analyses. Results: Both MYBL1 and MYBL2 were significantly upregulated in LGG compared with normal tissue (MYBL1: log2 fold change [log2FC] =0.710, FDR < 0.001; MYBL2: log2FC=1.379, FDR < 0.001). High MYBL1 expression was associated with inferior OS in the overall LGG cohort (HR=2.2; p=0.0014) and in astrocytoma (HR=3.4; p= 0.0017), but not in oligoastrocytoma (HR=2.2; p=0.13) or oligodendroglioma (HR=1.6; p=0.27). Similarly, elevated MYBL2 expression correlated with worse OS in the overall cohort (HR=2.1; p=0.005) and astrocytoma (HR=2.6; p=0.015), while no significant association was observed in oligoastrocytoma (HR=2.3; p=0.12) or oligodendroglioma (HR=1.3; p=0.6). In multivariate analysis, MYBL1 remained independently associated with poorer OS (HR=1.28, 95% CI 1.04–1.60, p=0.021), whereas MYBL2 did not retain independent prognostic significance. GSEA demonstrated significant enrichment of cell cycle progression, E2F targets, epithelial mesenchymal transition, DNA replication, and mitotic spindle pathways in tumors with high MYBL1/2 expression. Conclusions: MYBL1 and MYBL2 overexpression identify a proliferative subset of low-grade gliomas with poorer outcomes, especially in astrocytoma. Although both associate with aggressive transcriptional programs and reduced survival, only MYBL1 remains an independent prognostic factor after clinicomolecular adjustment, supporting its role as a potential prognostic biomarker.
Upcycling black tea waste into a bifunctional catalyst for efficient biodiesel production from waste cooking oil with kinetic and thermodynamic insights
New developments and applications of human organoids
Stable and Low‐Cost Organic Photovoltaics Without Conjugated Donors
ABSTRACT Despite significant advances in power conversion efficiency (PCE) exceeding 20%, organic photovoltaics (OPVs) face industrialization challenges due to inherent stability issues associated with conventional organic donors and hole transport layers. Here, we employ an inorganic p‐type semiconductor copper(I) thiocyanate (CuSCN) as a multifunctional component concurrently serving as donor and hole transport layer. Combined with the non‐fullerene acceptor L8‐BO, the bulk heterojunction device achieves a champion PCE of 7.21%. More importantly, the CuSCN‐based devices exhibit exceptional thermal stability, maintaining 80% of their initial efficiency ( T 80 ) for nearly 400 h at 85°C, far exceeding the T 80 of 3 to 33 h for OPVs based on conventional all‐organic active layers. Moreover, under ISOS‐L‐3 protocol (maximum power point tracking under 100 mW cm −2 illumination, 65°C, 50% relative humidity), the devices exhibit outstanding operational durability, sustaining approximately 50% of their initial efficiency after 900 h, in stark contrast to the rapid degradation observed in D18:L8‐BO and PM6:L8‐BO reference systems, which retain only 15% and 19%, respectively. This work underscores the potential of CuSCN in enabling efficient, durable, and industrially viable OPVs.
Artificial intelligence–assisted colonoscopy and adenoma detection: An updated systematic review and meta-analysis of 42 studies.
2 Background: Colonoscopy misses a meaningful proportion of adenomas, limiting preventive effectiveness. We updated the evidence to evaluate AI-assisted versus standard colonoscopy on adenoma detection rate (ADR), adenomas per colonoscopy (APC), adenoma miss rate (AMR), and withdrawal time. Methods: PubMed, Scopus, Embase, and the Cochrane Library were searched from inception to January 9, 2026 (PRISMA-compliant). Risk ratios (RRs) and mean differences (MDs) with 95% CIs were pooled using random-effects models. Heterogeneity was assessed by I² and τ²; prediction intervals (PIs) calculated. Robustness was evaluated by leave-one-out analyses, Baujat plots, Cook's d, and GOSH diagnostics; small-study effects by funnel plots. Results: Across 42 studies (n=34,699), AI increased ADR (RR 1.19, 95% CI 1.13–1.27; I²=67.2%; PI 0.96–1.56); leave-one-out estimates were stable (RR 1.21–1.23 across all omissions). Baujat and Cook's d identified Aniwan 2023 (RR 0.76; sole negative-direction study) and Gong 2020 (RR 2.11) as most influential; GOSH confirmed distributed heterogeneity. Funnel asymmetry was right-sided, consistent with small-study effects. APC increased across 29 studies (n=26,163; MD 0.21, 95% CI 0.15–0.27; I²=77.5%; PI −0.05 to 0.46); leave-one-out estimates were stable (MD 0.20–0.22). Lau 2024 and Tiankanon 2023 were the most influential studies; Wallace 2022 (MD −0.59) was the sole negative outlier but its omission did not shift the pooled estimate (MD 0.22; I²=77.3%). AMR was reduced across 6 studies (n=2,273; RR 0.53, 95% CI 0.36–0.78; I²=77.4%; PI 0.16–1.76); Lui 2023 (RR 1.47) was identified as the dominant heterogeneity source across all influence metrics — its omission shifted the pooled RR to 0.46 (0.36–0.59) with I² reducing to 58.4%, and GOSH showed a bifurcated distribution attributable to this study. The remaining five AMR studies were directionally consistent. Withdrawal time was longer with AI across 34 studies (n=29,156; MD 0.48 min, 95% CI 0.29–0.67; I²=85.8%; PI −0.54 to 1.49); Thiruvengadam 2024 omission produced the largest shift (MD 0.43; I²=84.5%); Baujat identified Gong 2020 and Thiruvengadam 2024 as most influential; GOSH confirmed distributed heterogeneity; funnel asymmetry was right-sided. Conclusions: AI-assisted colonoscopy improved ADR, APC, and AMR across 42 studies, with a modest increase in withdrawal time. Prediction intervals for all outcomes crossed the null, indicating benefit is not uniform across settings. Standardized trials stratified by endoscopist experience and practice volume are needed to identify which populations derive the most consistent benefit.
Malte Fischer
Li <sub>2</sub> CO <sub>3</sub> ‐Derived Low‐Cost Li <sub>2</sub> S for Sulfide Solid Electrolytes Exceeding 11 mS cm <sup>−1</sup>
ABSTRACT Sulfide solid electrolytes (SSEs) hold great promise for all‐solid‐state batteries (ASSBs), owing to their high ionic conductivity and excellent deformability. However, their practical application is severely hindered by high cost, primarily originating from lithium sulfide (Li 2 S), which accounts for ∼90% of the total SSE cost. Here, we report a novel strategy to produce low‐cost Li 2 S from lithium carbonate (Li 2 CO 3 ) via its reaction with ammonium thiocyanate (NH 4 SCN). This reaction generates only gaseous by‐products, eliminating purification procedures and enabling scalable production of high‐quality Li 2 S. The resulting Li 2 S enables the synthesis of representative SSEs, Li 5.4 PS 4.6 Cl 0.8 Br 0.8 (LPSCB) and Li 5.4 PS 4.6 Cl 1.6 (LPSC), with room‐temperature ionic conductivities of 11.33 and 7.94 mS cm −1 , respectively. When coupled with LiNbO 3 ‐coated LiNi 0.895 Co 0.077 Mn 0.028 O 2 cathode, ASSBs deliver discharge capacities of 192.2 and 198.8 mAh g −1 at 0.1C, and retain 94.85% and 94.89% of initial capacities after 800 cycles at 1C, respectively. Cost analysis reveal that the total cost of SSEs synthesized from this Li 2 CO 3 ‐derived Li 2 S is reduced by 86.6% and 88.5%, highlighting its significant techno‐economic advantages for commercializing SSEs toward ASSBs.
Enhancing human-dog interaction through deep learning and explainable AI
Prevailing views of cell senescence overlook its biological complexity
Prospective study of quantitative broadband diffuse optical spectroscopy for differential diagnosis of suspicious breast lesions.
31 Background: A definitive breast cancer diagnosis requires a biopsy. However, suspicious lesions classified BI-RADS 3 and lower are not indicated for biopsy, leading many patients to undergo extended imaging surveillance lasting 6 to 18 months. This period of uncertainty can cause significant stress and anxiety, and represents a missed opportunity for treatment if malignant. Light-based diffuse optical spectroscopy (DOS) has been investigated as a noninvasive and safe technique for breast cancer assessment due to its sensitivity to tissue composition [1-4]. In this prospective study, we evaluate the discriminative power of DOS for distinguishing suspicious benign and malignant breast lesions in patients undergoing biopsy. Methods: Sixty-eight women, eighteen years or older, with at least one suspicious breast lesion and scheduled for biopsy were enrolled. Imaging was done using a custom-made continuous-wave and frequency-domain DOS system. Measurements were acquired in a 4x4 or 5x5 grid pattern centered over the lesion with 1cm spacing and a 1cm buffer of normal tissue, depending upon lesion size. A mirrored measurement was collected on the contralateral breast. Tissue concentrations were obtained for oxyhemoglobin, deoxyhemoglobin, methemoglobin, water, lipids, and collagen [4]. The lesion region of interest was defined as the interior points of the grid. From those, the average absolute chromophore value, average lesion-to-normal (L/N) ratio, Z-score-normalized values, and malignancy probability were computed using a previously published model [3]. Results: Of the 68 enrolled subjects, 21 were excluded due to operator error (N=7), instrument failure (N=3), or insufficient signal-to-noise ratio (N=11). Among the remaining subjects, 14 had biopsy-confirmed malignant lesions, and 33 had benign lesions. Analysis of absolute concentrations revealed that collagen was significantly elevated (p=0.037) in malignant lesions compared with normal tissue, while methemoglobin approached significance (p=0.058); the other five chromophores did not present any significant differentiating power. For the z-score data, only 36 subjects were analyzed, and water was the only significant differentiator (p=0.039). Conclusions: Of the 68 enrolled subjects, 21 were excluded due to operator error. Among the remaining subjects, 14 had biopsy-confirmed malignant lesions, and 33 had benign lesions. Analysis of absolute concentrations revealed that collagen was significantly elevated (p=0.037) in malignant lesions compared with normal tissue, while methemoglobin approached significance (p=0.058); the other five chromophores did not present any significant differentiating power. For the z-score data, only 36 subjects were analyzed, and water was the only significant differentiator (p=0.039). Clinical trial information: N/A.
Stabilizing Water Dissociation Sites via Ethylenediamine Coordination for Industrial‐Current‐Density Alkaline Hydrogen Evolution Reaction
ABSTRACT Incorporating water dissociation sites into electrocatalysts significantly boosts the catalytic activity for the alkaline hydrogen evolution reaction (HER), yet the reconfiguration of these sites under industrial‐level current densities—an issue that has received limited prior attention—severely impairs catalytic stability. Herein, we construct a highly active and ultra‐stable hybrid electrocatalyst composed of metallic nickel and a hydroxy(ethylenediamine)nickel(II) complex (Ni[(OH) 2 en x ]/Ni) via a scalable cathodic alkalization strategy. The interface‐coupled Ni[(OH) 2 en x ] complex, featuring high oxophilicity and enhanced thermodynamical stability against reduction, not only accelerates the water‐dissociation step but also renders long‐term catalytic durability. The resulting hybrid catalyst delivers a low overpotential of 35.2 mV at 10 mA cm −2 and a small Tafel slope of 43.68 mV dec −1 , outperforming the benchmark Ni(OH) 2 /Ni and Ni(OH) 2 /Pt catalysts. When integrated into an anion‐exchange membrane water electrolyzer, the electrode delivers 500 mA cm −2 for 3000 h in 1.0 M KOH at 25°C. This work demonstrates the great potential of coordination complexes as robust active sites for Volmer step, a concept that can be extended to other electrocatalytic reactions involving water dissociation.
RiskSetDP: session-level differential privacy for survival analysis with risk-set–aware sensitivity control
In-cell chemistry enables discovery of cyclic peptide transcription factor inhibitors
Latent profiles of digital health technophobia and associated factors among older adults with cancer.
354 Background: As digital health technologies become increasingly embedded in oncology care, older adults with cancer are emerging as key users of these services. However, technophobia may hinder their engagement with digital health interventions and exacerbate digital disparities. Evidence regarding the heterogeneity of digital health–related technophobia and its determinants in this population remains limited. Methods: To identify distinct latent profiles of digital health technophobia among older adults with cancer and to examine factors associated with profile membership. Results: A cross-sectional study was conducted from November 2023 to July 2024 among 307 older adults with cancer recruited from a tertiary hospital in Shandong Province, China. Participants completed the Technophobia Scale, eHealth Literacy Scale, and General Self-Efficacy Scale. Latent profile analysis (LPA) was performed to identify subgroups based on technophobia patterns. Multinomial logistic regression analyses were conducted to examine factors associated with profile membership. Conclusions: Three distinct technophobia profiles were identified: Low Technophobia (50.2%), Moderate Technophobia with Predominant Techno-Anxiety (19.2%), and High Technophobia (30.6%). Higher general self-efficacy was associated with lower likelihood of membership in the moderate and high technophobia profiles. Smartphone use by patients and caregivers, online health information–seeking behaviors, and following the hospital’s official social media account were significantly associated with profile membership (all P < 0.05).
Unassisted Electrocatalytic Hydrogenation Coupled With Aldehydes Oxidation on Bifunctional Pd–Cu Synergistic Sites
ABSTRACT Paired electrolysis enhances energy utilization efficiency by coupling anodic oxidation with cathodic reduction reactions, enabling the simultaneous production of high‐value chemicals. However, achieving the transition from electricity consumption to electricity generation in paired electrolysis remains a huge challenge due to mismatched potentials of anodic and cathodic reactions and lack of highly efficient active sites. Herein, we designed an electrochemical system that couples cathodic hydrogenation of various unsaturated compounds with anodic aldehydes oxidation reactions at a synergistic Pd–Cu bifunctional site. The paired hydrogenation and oxidation reactions were demonstrated to produce valuable products at both electrodes simultaneously without electrical energy input. Experimental studies and theory calculations indicate a Pd–Cu cooperative mechanism, which optimizes hydrogen transfer kinetics in both hydrogenation and oxidation reactions. Specifically, the Pd site promotes water dissociation to generate active hydrogen, which then spillover to the adjacent Cu site to catalyze hydrogenation, while the Pd site modulates the electronic structure of the Cu site, promoting C─H bond cleavage and facilitating H 2 generation during aldehydes oxidation. This study demonstrates that precise catalyst design and reaction system optimization can achieve efficient synergy between oxidation and reduction reactions in paired electrolysis, offering new insights and technological pathways for electrochemical synthesis of high‐value chemicals.
A resurrection experiment reveals the evolution of jack-and-master plasticity in a Mediterranean shrub
Tri-marker model integrating BCL2A1 expression in CD8⁺ T cells, PD-L1, and HOT score as a predictor of immune checkpoint blockade response in lung adenocarcinoma: A multi-cohort integrative analysis.
291 Background: Despite advances in immune checkpoint blockade (ICB) for advanced lung adenocarcinoma (LUAD), predictive biomarkers beyond PD-L1 remain limited. This retrospective correlative study characterizes BCL2A1 expression in CD8⁺ T cells as a novel biomarker and evaluates its integration into a tri-marker predictive model. Methods: Publicly available bulk and single-cell RNA-seq datasets from ICB-treated LUAD patients were analyzed (discovery cohort, n = 60; five validation cohorts, n = 126). Inclusion required pathologically confirmed LUAD and pre-treatment tumor transcriptomes. Subgroups included ICB-treated vs. non-ICB cohorts. Primary endpoint: overall survival (OS); secondary: predictive AUC. This exploratory retrospective bioinformatics study used existing datasets without formal power calculation (assumed detectable HR < 1; null HR = 1). Assay: RNA sequencing; expression quantified as TPM/log2 counts, primarily continuous. Dichotomization cut-points for BCL2A1, PD-L1, and HOT score were optimized by Youden's index in discovery and locked for validation. Validation performance used leave-one-cohort-out (LOCO) cross-validation with macro-AUC averaging. No multiple testing correction beyond benchmarking. Statistics: differential expression, Cox proportional hazards, logistic regression, AUC, and Spearman correlation; full cohorts analyzed. Results: Single-cell analyses revealed BCL2A1 enrichment in tissue-resident memory and proliferating CD8⁺ T-cell subsets, with inferred increased outgoing signaling via the MIF pathway (p = 0.0278). In bulk cohorts, high BCL2A1 expression was significantly associated with improved OS in ICB-treated patients (HR = 0.43; 95% CI: 0.21–0.87; p < 0.05), but not in non-ICB cohorts, indicating treatment-specific relevance. The tri-marker model (BCL2A1, PD-L1 expression, and 27-gene HOT score) demonstrated robust predictive performance (discovery AUC = 0.826; validation macro-AUC = 0.774), outperforming PD-L1 alone (AUC = 0.706) and established signatures (TIDE, IPS, TIS, IFNG). Cross-platform in-silico reproducibility of marker expression and model scores was high (Spearman ρ = 0.982–0.993). Conclusions: BCL2A1 characterizes a CD8⁺ T-cell state linked to favorable ICB outcomes in LUAD. The tri-marker model offers a reproducible and superior predictive tool for patient stratification, supporting prospective clinical validation as a transcriptional biomarker.
Facile B–N Covalent Bond Fusion in <i>N</i> , <i>N′</i> ‐Diaryldihydrophenazines: Achieving Efficient Narrowband Electroluminescence and Controlled Redox Activity
ABSTRACT Covalently fusing multiple B–N units into redox‐active polycyclic aromatic hydrocarbons (PAHs) offers a powerful strategy for creating π‐extended systems with novel functionalities, but it remains a formidable challenge. Here, we report a facile, one‐pot, and lithium‐free NH‐directed borylation to construct a series of 5,10‐dihydro‐5,10‐diphenylphenazine (DPPA) derivatives fused by two or four B–N covalent bonds. Such a multiple B–N locking is found not only to enforce molecular rigidity and suppress excited‐state structural relaxation, but also to profoundly modulate the electronic structure and antiaromaticity of the central DPPA core. Interestingly, the resultant quadruply fused system (4BN‐Ph) can function as an unprecedented narrowband orange‐red thermally activated delayed fluorescence (TADF) emitter, enabling efficient electroluminescence with a record‐high external quantum efficiency of 31.2% and a notably small full‐width at half‐maximum of 32 nm at an emissive peak of 595 nm. Also, 4BN‐Ph displays intriguing redox‐controlled properties, since a stepwise oxidation generates near‐infrared‐absorbing open‐shell radical cations and closed‐shell dications. This work establishes a modular route to PAHs incorporating multiple B–N covalent bonds, with exceptional optoelectronic and spintronic properties.